Chi produce Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Reckitt Benckiser (Healthcare) SA-NV (BE)

A quale classe ATC appartiene Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: ATC A02BX13 Alginic Acid. ATC è la classificazione anatomica, terapeutica e chimica dell'OMS.

OTC

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.

Q: In quale forma farmaceutica è disponibile Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: Chewable tablet (Oral use)

Chewable tablet

INN: Sodium Alginate

Aggiornato: 2026-04-11

Disponibile in:

🇩🇪🇬🇧🇷🇴🇷🇺🇹🇷

Forma

Chewable tablet

Dosaggio

—

Via di somministrazione

Oral use

Conservazione

—

Informazioni sul prodotto

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.